Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.

Translated title of the contribution: Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.

G. Fatkenheuer, A.L. Pozniak, M.A. Johnson, A. Plettenberg, S. Staszewski, I.M. Hoepelman, M.S. Saag, F.D. Goebel, J.K. Rockstroh, B.J. Dezube, T.M. Jenkins, C. Medhurst, J.F. Sullivan, C. Ridgway, S.A. Abel, I.T. James, M. Youle, E. van der Ryst

Research output: Contribution to journalArticleAcademic

Translated title of the contributionEfficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.
Original languageUndefined/Unknown
Pages (from-to)1170-1172
Number of pages3
JournalNature Methods
Volume11
Issue number11
Publication statusPublished - 2005

Cite this